He summarized that urinary tract infections were not more frequent in KTR than in other patients who received SGLT2 inhibitors, and that bacterial genital infections were in the range expected in KTR in all studies and also seen in patients with type 2 diabetes. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.